Sernova Corp.

TSX:SVA.TO

Biotechnology

Healthcare
$0.14 -5.88%

-$0.01 today

Market cap
$50.98M
Beta
0.66
P/E (TTM)
-4.7
EPS (TTM)
-$0.03
52W Low $0.12High $0.21

Volume 0.55M

Average 0.12M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$10.91M

FY 2025 · Annual

Investing Cash Flow

$24,958.00

FY 2025 · Annual

-99.8% YoY

Financing Cash Flow

$5.14M

FY 2025 · Annual

+1.3% YoY

Cash Flow Statement

CAD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Net Income(6.97M)(24.42M)(39M)(32.19M)(15.74M)
Depreciation & Amortization267.2K440K445.55K540.28K342.59K
Deferred Income Tax0000(70K)
Stock-Based Compensation218.4K7.45M3.9M1.75M2.3M
Change in Working Capital517.56K2.95M4.99M11.16M1.74M
Accounts Receivables(89.8K)(195.04K)229.7K561.85K175.47K
Inventory00000
Accounts Payables00000
Other Working Capital607.35K3.14M4.76M10.6M1.56M
Other Non-Cash Items(881.36K)(838.57K)(676.34K)(150.48K)523.74K
Operating Cash Flow(6.84M)(14.42M)(30.34M)(18.9M)(10.91M)
Capital Expenditures(17.23K)(329K)(99.26K)0(3)
Acquisitions (Net)046M0024.96K
Purchases of Investments0(59M)(18.05M)00
Sales of Investments013M52.97M11.08M0
Other Investing Activities(211.55K)(46.01M)(35.3K)35.3K0
Investing Cash Flow(228.78K)(46.34M)34.78M11.12M24.96K
Debt Repayment(28K)(168.56K)(171.93K)(169.23K)4.94M
Common Stock Issued21.13M20.28M04.96M248.64K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities9.9M16.55M675.39K277.17K(47.93K)
Financing Cash Flow31M36.66M503.46K5.07M5.14M
Effect of Forex Changes00000
Net Change in Cash23.92M(24.1M)4.95M(2.71M)(5.75M)
Free Cash Flow(6.86M)(14.75M)(30.44M)(18.9M)(10.91M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$15.7M
+ D&A$342.6K
+ Stock-Based Comp$2.3M
- Deferred Tax-$70.0K
+ Working Capital$1.7M
+ Other Non-Cash$523.7K
= Operating Cash Flow-$10.9M
- Capex-$3
= Free Cash Flow-$10.9M

Analysis

FY2025 free cash flow is -$10.9M. FCF conversion is 69.3% of net income. Operating cash flow was -$10.9M, with capex of -$3. The largest bridge item is Stock-Based Comp at $2.3M.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

No filings found.

Does SVA.TO generate free cash flow?

Sernova Corp. (SVA.TO) generated -$10.91M of free cash flow in fiscal 2025.

How much operating cash flow does SVA.TO produce?

Operating cash flow was -$10.91M, before capital expenditures of $3.00.